These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6436650)

  • 21. Two Novel
    Zhao X; Dai Q; Jia R; Zhu D; Liu M; Wang M; Chen S; Sun K; Yang Q; Wu Y; Cheng A
    Front Cell Infect Microbiol; 2017; 7():391. PubMed ID: 28929089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of strain LT2-Ml in identifying the protective antigens in a Salmonella typhimurium-derived ribosomal vaccine.
    Lin JH; Berry LJ
    J Reticuloendothel Soc; 1978 Feb; 23(2):135-43. PubMed ID: 342689
    [No Abstract]   [Full Text] [Related]  

  • 23. Strain dependent variation of delayed-type hypersensitivity in Salmonella typhimurium infected mice.
    Killar L; Eisenstein TK
    Adv Exp Med Biol; 1983; 162():297-302. PubMed ID: 6346823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An enterobacterial common antigen mutant of Salmonella enterica serovar Typhimurium as a vaccine candidate.
    Bridge DR; Whitmire JM; Gilbreath JJ; Metcalf ES; Merrell DS
    Int J Med Microbiol; 2015 Sep; 305(6):511-22. PubMed ID: 26070977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection of mice against Salmonella typhimurium with an O-specific polysaccharide-protein conjugate vaccine.
    Watson DC; Robbins JB; Szu SC
    Infect Immun; 1992 Nov; 60(11):4679-86. PubMed ID: 1383154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Active immunization to experimental salmonellosis in mice protective properties of Salmonella R mutants against infection with different pathogenic Salmonella species (author's transl)].
    Schlecht S
    Zentralbl Bakteriol A; 1981 Aug; 249(3):362-72. PubMed ID: 7023133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Requirement of the conformational stability of a Salmonella ribosomal vaccine for its mouse protection.
    Kita E; Oku D; Nishikawa F; Emoto M; Yasui K; Kashiba S
    FEMS Microbiol Immunol; 1991 Aug; 3(4):229-39. PubMed ID: 1931135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specificity of protective immunity induced by porin from Salmonella typhimurium.
    Matsui K; Arai T
    Microbiologica; 1991 Apr; 14(2):103-12. PubMed ID: 1649959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective immunity induced by porin in experimental mouse salmonellosis.
    Matsui K; Arai T
    Microbiol Immunol; 1989; 33(9):699-708. PubMed ID: 2555656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective Immunity Elicited by Oral Immunization of Mice with
    Erova TE; Kirtley ML; Fitts EC; Ponnusamy D; Baze WB; Andersson JA; Cong Y; Tiner BL; Sha J; Chopra AK
    Front Cell Infect Microbiol; 2016; 6():148. PubMed ID: 27891321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effects of a supernatant factor from Salmonella typhimurium on Salmonella typhimurium infection of inbred mice.
    Plant J; Glynn AA; Wilson BM
    Infect Immun; 1978 Oct; 22(1):125-31. PubMed ID: 365739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulated delayed synthesis of lipopolysaccharide and enterobacterial common antigen of Salmonella Typhimurium enhances immunogenicity and cross-protective efficacy against heterologous Salmonella challenge.
    Huang C; Liu Q; Luo Y; Li P; Liu Q; Kong Q
    Vaccine; 2016 Aug; 34(36):4285-92. PubMed ID: 27423383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell-mediated immune response to Salmonella typhimurium infection in mice: development of nonspecific bactericidal activity against Listeria monocytogenes.
    Zinkernagel RM
    Infect Immun; 1976 Apr; 13(4):1069-73. PubMed ID: 819372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection of C3H/HeJ mice from lethal Salmonella typhimurium LT2 infection by immunization with lipopolysaccharide-lipid A-associated protein complexes.
    Killion JW; Morrison DC
    Infect Immun; 1986 Oct; 54(1):1-8. PubMed ID: 3531011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteins from Salmonella R-mutants mediating protection against Salmonella typhimurium infection in mice. III. Separation and purification of soluble proteins and their use as vaccines and as precipitating antigens.
    Bhatnagar N; Schlecht S
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Dec; 260(4):448-58. PubMed ID: 3914792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-protection induced in mice by immunizations with proteins of related bacteria species.
    Barber C; Eylan E
    Zentralbl Bakteriol Orig A; 1976 Jan; 234(1):46-52. PubMed ID: 56832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outer membrane vesicles derived from Salmonella Typhimurium mutants with truncated LPS induce cross-protective immune responses against infection of Salmonella enterica serovars in the mouse model.
    Liu Q; Liu Q; Yi J; Liang K; Liu T; Roland KL; Jiang Y; Kong Q
    Int J Med Microbiol; 2016 Dec; 306(8):697-706. PubMed ID: 27578609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delayed-type hypersensitivity and immunity to Salmonella typhimurium.
    Killar LM; Eisenstein TK
    Infect Immun; 1986 May; 52(2):504-8. PubMed ID: 3516875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum-mediated resistance induced with immunogenic preparations of Salmonella typhimurium.
    Venneman MR; Berry LJ
    Infect Immun; 1971 Oct; 4(4):374-80. PubMed ID: 4949497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of endotoxin contamination in ribiosomal vaccines prepared from Salmonella typhimurium.
    Misfeldt ML; Johnson W
    Infect Immun; 1977 Jul; 17(1):98-104. PubMed ID: 328399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.